Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 15/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | FPR2 | P25090 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4340575 | 0.88 | TRPV1 (0.54) | TRPV1OPRM1 | |
| SCHEMBL13613615 | 0.86 | TRPV1 (0.57) | TRPV1OPRM1 | |
| SCHEMBL4344935 | 0.85 | TRPV1 (0.52) | TRPV1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13613685 | 0.85 | TRPV1 (0.52) | TRPV1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13613682 | 0.85 | TRPV1 (0.52) | TRPV1LMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4336906 | 0.84 | TRPV1 (0.54) | TRPV1OPRM1 | |
| SCHEMBL5118025 | 0.82 | TRPV1 (0.49) | TRPV1OPRM1LMNA | |
| SCHEMBL5105662 | 0.82 | TRPV1 (0.49) | TRPV1OPRM1LMNA | |
| SCHEMBL5111558 | 0.82 | TRPV1 (0.49) | TRPV1OPRM1LMNA | |
| SCHEMBL13613614 | 0.78 | KDM4E (0.56) | TRPV1OPRM1L3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612113-B2 | Such as N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(7-hydroxy-5,6,7,8-tetrahydro-1-naphthalenyl)urea; vanilloid receptor antagonists; for treatment of urge urinary incontinence, overactive bladder, chronic pain, neuropathic pain, postoperative pain, rheumatoid arthritic pain, neuralgia, neuropathies, COPD | XENTION LIMITED (GB) | 2009-11-03 | — | — | US | disclosed |